Use of Virtual Reality in Pain Management in Hospitalized Patients

NCT05545033 | Completed

• 1 other identifier: VIRTUAL01
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Acute and chronic non-cancer pain is a common healthcare problem locally and globally, leading to many inpatient admissions for poorly controlled pain. The World Health Organisation has declared that access to adequate pain control is a fundamental human right. Yet in our current practice, both acute and chronic non-cancer pain remain poorly controlled. There is passive over-reliance on pharmacological agents and interventional procedures in the management of pain. The opioid epidemic with issues of dependence, misuse, and overdose is especially concerning. Therefore, there is a pertinent clinical need to find sustainable non-pharmacological adjuncts in the complex management of pain. Virtual reality (VR) involves the use of technology to create a three-dimensional multisensory artificial environment replacing real-world sensory inputs. Initially created solely for entertainment purposes, VR applications have since expanded and made its way into healthcare. In Pain Medicine, the application of VR has been promising. There is currently no VR study done in our local population who suffer from pain issues. In our study, we aim to test the feasibility of applying the use of VR in patients admitted inpatient due to pain issues. We believe that VR can be used as an adjunctive tool improve pain management and patient satisfaction.

Conditions

Pain, Acute; Pain, Chronic

Keywords

virtual reality; pain management; inpatients

Outcome Measures

Primary Outcomes (1)

• Patient acceptability and tolerability

  Validated questionnaires - patient experience satisfaction (0 to 10; 0-worst outcome, 10-best outcome), System Usability Scale (\<50-not acceptable, 50-70-marginal, \>70-acceptable)

  post-intervention (up to 1 hr)

Secondary Outcomes (1)

• Clinical efficacy of virtual reality

  pre- and post-intervention (up to 1hr)

Study Arms (1)

Virtual reality intervention

EXPERIMENTAL

Comparison of pain and anxiety levels before and after VR intervention within the same patient.

Device: Virtual reality

Interventions

Virtual reality DEVICE

5 to 15 minutes of virtual reality exposure

Virtual reality intervention

Eligibility Criteria

• Age: 21 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Hospitalised patients with complain of pain issues (at least one of the following),
• Acute pain
• Acute exacerbations of chronic pain
• Chronic non-cancer pain
• Post-procedural pain (limited to those who undergo procedures with \< 2 hours in duration)
• Age equal or more than ≥ 21 years,
• No visual or hearing impairment,
• English literacy.

You may not qualify if:

• Cancer-related pain,
• Comorbidities affecting usage of VR e.g. motion sickness, stroke, seizure, dementia, transmissible diseases, severe facial eczema,
• Undergoing litigation.

Sponsors & Collaborators

• Changi General Hospital: lead

Study Sites (1)

Changi General Hospital

Singapore, 529889, Singapore

Location

Related Publications (2)

• Mosadeghi S, Reid MW, Martinez B, Rosen BT, Spiegel BM. Feasibility of an Immersive Virtual Reality Intervention for Hospitalized Patients: An Observational Cohort Study. JMIR Ment Health. 2016 Jun 27;3(2):e28. doi: 10.2196/mental.5801.

  PMID: 27349654 BACKGROUND

• Jones T, Moore T, Choo J. The Impact of Virtual Reality on Chronic Pain. PLoS One. 2016 Dec 20;11(12):e0167523. doi: 10.1371/journal.pone.0167523. eCollection 2016.

  PMID: 27997539 BACKGROUND

MeSH Terms

Conditions

Acute Pain; Chronic Pain; Agnosia

Condition Hierarchy (Ancestors)

Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Perceptual Disorders; Neurobehavioral Manifestations; Nervous System Diseases

Study Officials

• Lydia Li

  Changi General Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Consultant, Department of Anaesthesia and Surgical Intensive Care

Model Details: Open-label, single centre, single-arm pilot study

Study Record Dates

• First Submitted: September 11, 2022
• First Posted: September 19, 2022
• Study Start: January 20, 2021
• Primary Completion: March 16, 2022
• Study Completion: March 16, 2022
• Last Updated: September 19, 2022

Record last verified: 2022-09

Data Sharing

• IPD Sharing: Will not share

Locations

SG (1)